A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

Affiliation auteurs!!!! Error affiliation !!!!
TitreA 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
Type de publicationJournal Article
Year of Publication2017
AuteursCorpechot C., Chazouilleres O., Rousseau A., Guyader D., Habersetzer F., Mathurin P., Goria O., Potier P., Minello A., Silvain C., Abergel A., Debette-Gratien M., Larrey D., Roux O., Bronowicki J.-P, Boursier J., De Ledhingen V., Heurgue-Berlot A., Nguyen-Khac E., Zoulim F., Ollivier-Hourmand I., Zarski J.-P, Nkontchou G., Gaouar F., Simon T., Poupon R.
JournalJOURNAL OF HEPATOLOGY
Volume66
PaginationS89
Type of ArticleMeeting Abstract
ISSN0168-8278
DOI10.1016/S0168-8278(17)30442-7